Back to trials
completed
Not Applicable

NCT03607617

ASCEND: ApproacheS to CHC ImplEmeNtation of SDH Data Collection and Action

Sponsored by Kaiser Permanente

Summary

This work will test a set of strategies for helping community health centers (CHCs) routinely identify and take action on the SDH-related needs of patients with / at risk for DM using a stakeholder-driven process to develop EHR-based SDH data collection / summary tools for CHCs.

Eligibility Criteria

Inclusion Criteria: * Any persons who are at risk for type 2 diabetes * May include some subjects with mental health conditions of various types; however, it is important to systematically address high DM /obesity risk in this population, because such patients may be at risk for elevated high DM /obesity risk and have often been excluded or underrepresented in previous research studies. * Decisionally/cognitively impaired * Economically/educationally disadvantaged * Non-English Speakers * Elderly Exclusion Criteria: * Neonates of uncertain viability or nonviable neonates (up to 28 days post birth) * Prisoners Note: The investigators are not enrolling patients for this clinic-randomized study, but rather studying the uptake and impact of a set of EHR-based clinical decision support tools into regular care at the participating clinics. In this clinic-randomized trial, the intervention / randomization are clinic level. The intervention targets clinic processes that are part of the regular care patients receive, and will not require special visits.

Locations (1)

Kaiser Permanente Center for Health Research

Portland, Oregon, United States

Why you can trust this information
Registry sourcesclinicaltrials_gov
Source last updated1/22/2026
Clintriva indexed9/27/2026, 9:24:19 PM
Registry records1
Relationships needing review0

Identity-resolution confidence concerns registry/entity resolution and does not determine clinical eligibility.

Interested in this trial?

Express your interest and we'll connect you with the trial team.

Your selected profile and contact information may be shared with an authorised trial site, sponsor, or Clintriva coordination team for trial contact and pre-screening. Expressing interest does not mean you are eligible or enrolled.

Quick Facts
Start DateSep 3, 2018
CompletionJan 15, 2022
Enrollment0/31
CountryUnited States

Conditions

Diabetes Mellitus
View on registry
Clintriva
GDPR Controls Mapped HIPAA Safeguards Mapped NHS DSP Controls Mapped SOC 2 Controls Mapped

© 2026 Clintriva. All rights reserved.